Pressure-sensitive lens tolerable and safe for 24 hours

Article

A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy subjects and glaucoma sufferers.

A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy subjects and glaucoma sufferers, according to a paper in the Journal of Glaucoma.

Dr Katrin Lorenz et al., Department of Ophthalmology, University Medical Centre, Johannes Gutenberg-University Mainz, Germany, included 20 healthy subjects and 20 age-matched glaucoma patients in a prospective, single-centre, open, observational parallel group study.

The study incorporated the Sensimed Triggerfish Sensor, a soft disposable contact lens embedded with a telemetry chip and strain gauge sensor for continuous IOP monitoring. The sensor was implanted in one eye of each patient for 24 hours. A visual analogue scale was used to evaluate tolerability. The safety parameters included best-corrected visual acuity, pachymetry, epithelial defects, conjunctival erythema and corneal topography.

The 24-hour wearing period was completed by 19 healthy participants and 19 glaucoma patients. Pain or inappropriate fitting of the sensor contributed towards early discontinuation. Mean tolerability was 21.8 in the healthy group and 26.8 in the glaucoma group.

Corneal epithelial staining increased from 0.4 and 1.0 at baseline to 1.8 and 2.8 in the healthy and glaucoma groups, respectively. There were no statistically differences between the two groups, meaning they both had a similar safety and tolerability profiles.

To read the abstract please click here.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.